# Final Report

## Executive Summary
This dataset is suitable for exploratory and predictive analysis in the **Healthcare Risk** domain. The estimated data quality score is **92/100**, which indicates a **high** readiness level for downstream analytics. With targeted preprocessing, target validation, and baseline benchmarking, the dataset can support KPI monitoring, signal ranking, and early-stage machine learning workflows.

## Target Validation
The most likely target variable is **HeartDiseaseRisk**, and the inferred task type is **Classification**. Confidence in this target selection is **Moderate**, with ambiguity status set to **True**. The target selection appears aligned with the likely business objective.

## Key Data Quality Findings
The dataset contains approximately **13664 rows** and **28 columns**.  
- **Critical Issues:** No critical issues were explicitly detected  
- **Moderate Issues:** Minor missing values in non-critical columns  
- **Recommended Remediation:** Proceed with light preprocessing, Validate feature types before training  

This indicates that the dataset is analytically useful, but some preprocessing steps should be completed before production-grade modeling.

## Key Statistical / Analytical Findings
Outlier concentration in numeric fields may affect KPI interpretation and model stability if not addressed. These findings should be interpreted as directional analytical evidence rather than proof of causality.

## KPI Highlights
- **Average Biomarker Score** should be monitored across time, segments, and operational slices to surface actionable performance patterns.
- **Risk Prevalence** should be monitored across time, segments, and operational slices to surface actionable performance patterns.
- **Positive Class Rate** should be monitored across time, segments, and operational slices to surface actionable performance patterns.

## Signal Ranking Highlights
The preliminary signal ranking suggests the following variables are the strongest contributors:
- **Glucose**: estimated importance **0.28**
- **Insulin**: estimated importance **0.23**
- **Age**: estimated importance **0.23**

## Visualization Insights
- **Age vs Risk** can support trend detection, anomaly review, and stakeholder interpretation.
- **Biomarker Correlation Heatmap** can support trend detection, anomaly review, and stakeholder interpretation.

## ML Readiness Assessment
The dataset is currently assessed as **Conditionally Ready** for machine learning.  
- **ML Ready:** True  
- **Class Imbalance Flag:** True  
- **Potential Leakage Risk:** Potential target leakage in engineered columns  
- **Recommended Preprocessing:** Drop leakage-prone columns, Handle class imbalance, Review missing value strategy  
- **Suggested Baseline Models:** Logistic Regression, XGBoost Classifier  

## Risks / Cautions
Identifier-like columns may distort signal ranking if retained in the modeling set. These issues should be addressed before treating model performance as production-ready.

## Actionable Recommendations
1. Review subgroup performance to ensure the model generalizes across segments.
2. Impute missing values using domain-aware methods instead of blanket defaults.
3. Benchmark at least two baseline models before selecting a production candidate.

## Conclusion
This report provides a structured assessment of **healthcare_risk_073.csv** and indicates that the dataset has meaningful analytical value. With proper target validation, data cleaning, leakage review, and baseline model benchmarking, it can support both business intelligence workflows and early-stage predictive modeling.
